Sue J. Moon

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

HSF1-DBC1 axis drives prostate cancer progression by activating a metastatic transcriptional program.

HSF1-DBC1 axis drives prostate cancer progression by activating a metastatic transcriptional program.

Journal: Experimental & molecular medicine

Published: December 21, 2024

Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.

Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.

Journal: Experimental & molecular medicine

Published: February 23, 2023

DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.

DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.

Journal: Nucleic acids research

Published: May 12, 2022

Sequence variants in the proximal promoter and +5.8-kb site of ABO in Koreans with weak B phenotypes.

Sequence variants in the proximal promoter and +5.8-kb site of ABO in Koreans with weak B phenotypes.

Journal: Vox sanguinis

Published: April 16, 2021

Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.

Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.

Journal: Theranostics

Published: August 03, 2020

The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease.

The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease.

Journal: Infection & chemotherapy

Published: May 29, 2020

Contribution of Personality Traits, Psychological Factors, and Health-Related Quality of Life to Medication Adherence in Patients with Rheumatoid Arthritis.

Contribution of Personality Traits, Psychological Factors, and Health-Related Quality of Life to Medication Adherence in Patients with Rheumatoid Arthritis.

Journal: Yonsei medical journal

Published: January 08, 2020

DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.

DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.

Journal: Cell death & disease

Published: April 12, 2018

DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.

DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.

Journal: Oncogene

Published: May 19, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026